Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Ashley Grossman, Professor of Endocrinology at the Oxford Centre for Diabetes, Endocrinology and Metabolism, has been awarded the prestigious Geoffrey Harris Prize Lecture from the European Society of Endocrinology. Professor Grossman will deliver the lecture during the first session of the society’s annual meeting next week in Poland.

Ashley GrossmanThe prize, worth €12000 and sponsored by Ipsen, is the first of its kind in Europe and is awarded to established researchers in the field of neuroendocrinology. It is named in honour of Oxford University’s Professor Geoffrey Harris, one of the leading pioneers of neuroendocrinology.

Professor Grossman commented: "I am really honoured to have been awarded this prize, celebrating research into the field neuroendocrinology which includes studies of disorders of the hypothalamus and pituitary. These areas of the brain and endocrine system respectively reveal the intimate connections between 'brain, mind and body', and have fascinated me since I was an undergraduate in Psychology. More recently, I have been involved in research to understand the development of pituitary tumours, which are helping to identify the earliest stages of tumorigenesis. I am especially delighted that I now work at a university where Geoffrey Harris made his ground-breaking researches into the connections between brain and hormones, in the Department of Human Anatomy in South Parks Road (which later joined the Laboratory of Physiology to form the Department of Physiology, Anatomy and Genetics); if it were not for his premature death, it is highly likely he would have gone on to be awarded the Nobel Prize in association with Andrew Schally and Roget Guillemin who sequenced the first hypothalamic hormones. At the Oxford Centre for Diabetes, Endocrinology and Metabolism, our in-patient ward is named Geoffrey Harris in his honour."

Links:

European Society of Endocrinology

Similar stories

MRC HIU appoints new Director

Awards and Appointments General

We are pleased to announce that Professor Alison Simmons has been appointed as the new Director of the MRC Human Immunology Unit.

New Year's Honours 2021

Awards and Appointments General

Members of the Medical Sciences Division have been recognised in the New Year's Honours list for 2021.

Oxford University awarded £2.4 million to fund DPhil research in inflammation, immunology and musculoskeletal disease

Awards and Appointments General

Oxford University has been awarded a £2.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.

Professor Sir Rory Collins awarded the MRC Millennium Medal 2020

Awards and Appointments General

Professor Sir Rory Collins, Head of the Nuffield Department of Population Health, and Principal Investigator and Chief Executive of UK Biobank, has been awarded the Medical Research Council (MRC) Millennium Medal 2020, the MRC’s most prestigious personal award.

University spinout PepGen awarded major financing to target Duchenne muscular dystrophy

Awards and Appointments General Innovation

PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.

£3M invested to drive forward early translation through five new Oxford-Bristol Myers Squibb Fellowships

Awards and Appointments General

Five new Oxford-Bristol Myers Squibb Fellowships representing an investment of £3M have been announced today*. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.